𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tall Cell Variant of Papillary Thyroid Microcarcinoma: Clinicopathologic Features with BRAF V600E Mutational Analysis

✍ Scribed by Bernstein, Jane; Virk, Renu K.; Hui, Pei; Prasad, Avinash; Westra, William H.; Tallini, Giovanni; Adeniran, Adebowale J.; Udelsman, Robert; Sasaki, Clarence T.; Roman, Sanziana A.; Sosa, Julie A.; Prasad, Manju L.

Book ID
121313397
Publisher
Mary Ann Liebert
Year
2013
Tongue
English
Weight
253 KB
Volume
23
Category
Article
ISSN
1050-7256

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Papillary microcarcinoma in comparison w
Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAFV600E mutation, clinicopathological features, and immunohistochemical findings
✍ Young Joo Park; Young A. Kim; You Jin Lee; Soon Hui Kim; So Yeon Park; Kyung Won πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 1 views

## Abstract ## __Background.__ Papillary thyroid microcarcinoma (PMC; ≀1 cm) is thought to take a benign course during the lifetime. However, recent studies showed high recurrence rates for PMC. ## __Methods.__ We analyzed the clinicopathological features, long‐term prognosis, and some molecular

Clinicopathologic significance of BRAF V
Clinicopathologic significance of BRAF V600E mutation in papillary carcinomas of the thyroid : A meta-analysis
✍ Ju-Han Lee; Eung-Seok Lee; Young-Sik Kim πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 699 KB

## Abstract ## BACKGROUND. Numerous studies have investigated the clinical significance of __BRAF__ mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on the usefulness of __BRAF__ mutation as a prognostic marker of PTC. To address this controversy, the freque